¿Prefieres las Guías Europeas ESC traducidas al Español? Pincha AQUÍ
Guías de Miocardiopatías: hipertrófica, restrictiva, constrictiva
- 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines »
- 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC) »
- 2022 ESC Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the HFA and the Working Group on Myocardial Function of the ESC »
- 2011 ACCF/AHA para el Diagnóstico y Tratamiento de la Miocardiopatía Hipertrófica »
Otros documentos de interés:
- 2022 ESC Interpretation and Actionability of Genetic Variants in Cardiomyopathies: a Position Statement from the European Society of Cardiology Council on Cardiovascular Genomics »
- Task Force 2010 Diagnóstico de la Miocardiopatía/Displasia Arritmogénica del Ventrículo Derecho »
